3628 results for «701»
3628 results
Beyond valves: expanding the structural toolbox
19 May 2026 – From EuroPCR 2026
This session expands the scope of structural heart interventions beyond valve therapies. It covers embolic protection in high-risk intracardiac procedures, outcomes of paravalvular leak closures, novel aortic root stent-graft research, cerebral ischemia predictors after TEVAR, and transcatheter ASD closure techniques.
Choosing the right tool to treat calcified bifurcation
19 May 2026 – From EuroPCR 2026
This session provides expert guidance on managing calcified bifurcation lesions. It highlights identification of high-risk scenarios, the role of coronary CT angiography and intravascular imaging in tool selection, and specialized techniques for treating calcified nodules in the left main coronary artery.
Outcomes in tricuspid valve intervention
19 May 2026 – From EuroPCR 2026
This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
20 May 2026 – From EuroPCR 2026
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...
A critical appraisal of the recent evidence in the LAA closure field
20 May 2026 – From EuroPCR 2026
This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke...
STEMI presenting with cardiogenic shock
19 May 2026 – From EuroPCR 2026
This session covers acute management of STEMI presenting with cardiogenic shock, illustrating advanced interventional strategies and support devices such as ECMO, IABP, and Impella. It reviews complex clinical scenarios including acute left main occlusion and multivessel disease, offering critical insights into emergent care and decision-making.
Leaflet modification techniques during TAVI
19 May 2026 – From EuroPCR 2026
This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Thrombectomy in pulmonary embolism
19 May 2026 – From EuroPCR 2026
This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...
Place of DCB in clinical practice
19 May 2026 – From EuroPCR 2026
This session explores the clinical applications of drug-coated balloons (DCB) across diverse challenging scenarios. It covers management of severely calcified nodules in acute coronary syndrome, healing of intentional dissections in chronic total occlusions using paclitaxel DCB, strategic integration of contemporary technology in complex lesion treatment, and...
Complex anatomy in STEMI patients
19 May 2026 – From EuroPCR 2026
This session addresses the unique challenges posed by complex coronary anatomy in STEMI patients. Through detailed case discussions, it highlights management of anomalous culprit origins, multifaceted infarcts, rare presentations, and urgent primary PCI strategies in anatomically complex scenarios. The session emphasizes adaptive techniques to navigate unexpected...
When a primary PCI goes wrong
19 May 2026 – From EuroPCR 2026
This session investigates complications encountered during primary percutaneous coronary interventions (PCI). It covers management of no-reflow phenomena, innovative guide extension catheter aspiration techniques for thrombus-rich STEMI, challenges when balloon crossing fails, vein graft PCI pitfalls, and complex concurrent ischemic events involving myocardial infarction and limb ischemia....
To rescue the unexpected complications during TAVI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of unexpected complications during TAVI procedures. Through cases from Hong Kong, Kazakhstan, and Uzbekistan, it examines mechanisms underlying common and rare complications such as aortic sinus injury, acute valve dislocation, and left main collapse. Attendees gain practical insights...
Regulatory and reimbursement pathways for MedTech innovators
19 May 2026 – From EuroPCR 2026
This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the...
Lessons from the long-term DES data: how they can inform today's practice
20 May 2026 – From EuroPCR 2026
This session reviews long-term clinical data on drug-eluting stents (DES) and bioresorbable scaffolds (BRS), offering valuable insights to inform current interventional cardiology practice. It covers seven-year outcomes of magnesium scaffolds in ACS, five-year results of sirolimus-eluting iron BRS, and extensive post-market studies of various thin-strut and...
TAVI procedural complications - Part 4: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...
Vascular access: femoral and radial
20 May 2026 – From EuroPCR 2026
This session explores vascular access techniques in interventional cardiology, emphasizing both femoral and radial approaches. It covers access-related bleeding and ischemic complications, safety and efficacy of distal radial programs, and innovations in sheath technology. Additional topics include post-procedural mobilization, management of radial artery recanalization, balloon fenestration...
Double face of DCB in clinical practice
20 May 2026 – From EuroPCR 2026
This session examines the dual aspects of drug-coated balloons (DCB) in clinical practice through diverse case studies. Topics include DCB use in left main STEMI, OCT-guided management of in-stent restenosis, expanding indications for complex PCI, and challenges such as DCB failure and decision-making between drug-eluting balloons...
Advanced mitral TEER strategies in complex clinical scenarios
20 May 2026 – From EuroPCR 2026
This session presents advanced strategies for mitral transcatheter edge-to-edge repair (TEER) in complex clinical settings. Through cases involving surgical ring dehiscence, acute mitral regurgitation, dextrocardia, congenital anomalies, severe annular calcifications, and creative procedural approaches, it explores the expanding role of TEER. The session provides guidance on...